Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
Therese SjöholmAlexander KorenyushkinGustav GammelgårdTina SarénTanja LövgrenAngelica LoskogMagnus EssandJoel KullbergGunilla EnbladHåkan AhlströmPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2022)
EudraCT 2016-004043-36.